171 related articles for article (PubMed ID: 10491530)
1. Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.
Iwamura M; Wu W; Muramoto M; Ohori M; Egawa S; Uchida T; Baba S
Cancer; 1999 Sep; 86(6):1028-34. PubMed ID: 10491530
[TBL] [Abstract][Full Text] [Related]
2. Common expression of parathyroid hormone-related protein and no correlation of calcium level in renal cell carcinomas.
Gotoh A; Kitazawa S; Mizuno Y; Takenaka A; Arakawa S; Matsumoto O; Kitazawa R; Fujimori T; Maeda S; Kamidono S
Cancer; 1993 May; 71(9):2803-6. PubMed ID: 8467460
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer.
Iwamura M; di Sant'Agnese PA; Wu G; Benning CM; Cockett AT; Deftos LJ; Abrahamsson PA
Cancer Res; 1993 Apr; 53(8):1724-6. PubMed ID: 8467485
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma with rhabdoid features.
Gökden N; Nappi O; Swanson PE; Pfeifer JD; Vollmer RT; Wick MR; Humphrey PA
Am J Surg Pathol; 2000 Oct; 24(10):1329-38. PubMed ID: 11023094
[TBL] [Abstract][Full Text] [Related]
6. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia.
Abdeen O; Pandol SJ; Burton DW; Deftos LJ
Am J Gastroenterol; 1995 Oct; 90(10):1864-7. PubMed ID: 7572910
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
11. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
12. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma.
Tsuchimochi M; Kameta A; Sue M; Katagiri M
Odontology; 2005 Sep; 93(1):61-71. PubMed ID: 16170479
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
15. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
16. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.
Schweitzer DH; Boxman IL; Löwik CW; van Krieken JH; Weissglas MG; Baatenburg de Jong RJ; Papapoulos SE
J Clin Pathol; 1995 Oct; 48(10):896-900. PubMed ID: 8537484
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.
Guo J; Tretiakova MS; Troxell ML; Osunkoya AO; Fadare O; Sangoi AR; Shen SS; Lopez-Beltran A; Mehra R; Heider A; Higgins JP; Harik LR; Leroy X; Gill AJ; Trpkov K; Campbell SC; Przybycin C; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2014 Nov; 38(11):1457-67. PubMed ID: 25093518
[TBL] [Abstract][Full Text] [Related]
19. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
